Nutritional Management of Post COVID-19 Cognitive Symptoms

University of Alberta

Status

Enrolling

Conditions

Long COVID

Treatments

Dietary Supplement: medium chain triglyceride oil

Dietary Supplement: Safflower oil

Study type

Interventional

Funder types

Other

Identifiers

NCT05705648

Pro00109795

Details and patient eligibility

About

The goal of this clinical trial is to learn about in brain "fog" complaints associated with long-COVID in people aged 22-50-years. The main questions it aims to answer are:

the natural course of brain "fog" complaints
the effect, if any of supplemental dietary oil on brain "fog" complaints Participants will be asked to undergo some brain testing (X-rays and questions. Treatments they'll be given will be one of two supplemental oils to consume daily.

Researchers will compare outcomes in the two different oil groups to see if it has any effect on brain "fog" complaints.

Full description

Randomized placebo-control clinical trial comparing two types of nutritional oil and evaluating the impact, if any, on subjective complaints of long-COVID cognitive changes.

Enrollment

100 estimated patients

Sex

All

Ages

22 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

confirmed COVID infection, at least 3 months previously, with ongoing cognitive complaints
all other medical conditions stable, and on stable doses of medications (if required)

Exclusion criteria

COVID infection not confirmed by PCR or Rapid test
unable to speak English
pre-COVID cognitve complaints, and/or medical diagnoses affecting cognitive function